Product Description
Overall, the global glaucoma shunt market was valued at approximately $114 million in 2022. This is expected to increase over the forecast period at a CAGR of 4.7% to reach approximately $158 million.
Throughout this medical market research, we analyzed over 10 glaucoma shunt companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite includes a comprehensive analysis of the global glaucoma shunt market.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2029, and Historical Data to 2019
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Glaucoma Shunt Market Insights
Anticipated growth in unit sales is a response to the aging population, with the most significant increase expected in Central & Eastern Europe, followed by the Middle East.
Global Glaucoma Shunt Market Share Insights
- In 2022, New World Medical maintained its enduring leadership in the glaucoma shunt market, holding a significant majority share.
- J&J Vision Care secured the second-place position in the glaucoma shunt market during 2022. The company offers three models of its Baerveldt® glaucoma implants, including the Baerveldt® Pars Plana BG 102-350, Baerveldt® BG 101-350, and the Baerveldt® BG 103-250.
- Corza Medical, which acquired Katena Products, claimed the third-leading spot in the glaucoma shunt market in 2022. The company provides the Molteno™ and Molteno3™ drainage implants originally developed by Molteno Ophthalmic Limited.
Market Segmentation Summary
- Glaucoma Shunt Market
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2022 |
| Forecast | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
